Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial-Reference-Cited by-同舟云学术

Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial

Published:2017-02 Issue:2 Volume:5 Page:135-146
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Marty Francisco M,Vidal-Puigserver Joan,Clark Carol,Gupta Sandeep K,Merino Esperanza,Garot Denis,Chapman Marianne J,Jacobs Frédérique,Rodriguez-Noriega Eduardo,Husa Petr,Shortino Denise,Watson Helen A,Yates Phillip J,Peppercorn Amanda F

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference18 articles.

1. Statistical estimates of absenteeism attributable to seasonal and pandemic influenza from the Canadian Labour Force Survey;Schanzer;BMC Infect Dis,2011

2. Influenza–associated hospitalizations in the United States;Thompson;JAMA,2004

3. Mortality associated with influenza and respiratory syncytial virus in the United States;Thompson;JAMA,2003

4. Clinical implications of antiviral resistance in influenza;Li;Viruses,2015

5. 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro;Woods;Antimicrob Agents Chemother,1993

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genotypic and phenotypic susceptibility of emerging avian influenza A viruses to neuraminidase and cap-dependent endonuclease inhibitors;Antiviral Research;2024-09

2. Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomised controlled trials;The Lancet;2024-08

3. CD388: A universally protective Drug-Fc Conjugate that targets influenza virus neuraminidase;2024-06-04

4. Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomized controlled trials;2024-05-28

5. Passive immunotherapies for the next influenza pandemic;Reviews in Medical Virology;2024-04-18